1,25-Dihydroxyvitamin D3-induced apoptosis of retinoblastoma cells is associated with reciprocal changes of Bcl-2 and bax

Experimental Eye Research

Volumn 77, Issue 1, 2003, Pages 1-9

  Wagner, Nicole ^a   Wagner, Kay Dietrich ^a   Schley, Gunnar ^a   Badiali, Lucia ^a   Theres, Heinz ^a   Scholz, Holger ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Apoptosis; Cell cylce arrest; Cell growth; Flow cytometry; Immunohistochemistry; Retinoblastoma; TUNEL labelling; Vitamin D; Y79 cells

Indexed keywords

CALCITRIOL; DNA FRAGMENT; LEXACALCITOL; LIPOCORTIN 5; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; CONTROLLED STUDY; DRUG POTENCY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NICK END LABELING; PRIORITY JOURNAL; RETINOBLASTOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL;

EID: 0038772000     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4835(03)00108-8     Document Type: Article

References (46)

1. Albert D.M., Marcus D.M., Gallo J.P., O'Brien J.M. The antineoplastic effect of vitamin D in transgenic mice with retinoblastoma. Invest. Ophthalmol. Vis. Sci. 33:1992;2354-2364.
2. Albert D.M., Nickells R.W., Gamm D.M., Zimbric M.L., Schlamp C.L., Lindstrom M.J., Audo I. Vitamin D analogs, a new treatment for retinoblastoma: the first Ellsworth lecture. Ophthalmic Genet. 23:2002;137-156.
3. Albini A., Noonan D.M., Melchiori A., Fascina G.F., Precario M., Gentleman S., Toffenetti J., Chader G.J. Laminin-induced retinoblastoma cell differentiation: possible involvement of a 100-kDa cell-surface laminin-binding protein. Proc. Natl. Acad. Sci. USA. 89:1992;2257-2261.
4. Assaf A.A., Phillips C.I. Spontaneous regression of unilateral retinoblastoma in a father of three sons with retinoblastoma. Ophthalmic Paediatr. Genet. 6:1985;179-182.
5. Ausubel F.M. Current protocols in molecular biology. 2001;John Wiley and Sons, Inc, New York.
6. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem. Pharmacol. 42:1991;1569-1575.
7. Blutt S.E., McDonnell T.J., Polek T.C., Weigel N. Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2. Endocrinology. 141:2000;10-17.
8. Brodwall J. Spontaneous regression of a retinoblastoma. Acta Ophthalmol. (Copenh). 59:1981;430-434.
9. Büchi E.R., Bernauer W., Daicker B. Cell death and disposal in retinoblastoma: an electron microscopic study. Graefe's Arch. Clin. Exp. Ophthalmol. 232:1994;635-645.
10. Campbell M.A., Chader G.J. Effects of laminin on attachment, growth and differentiation of cultured Y-79 retinoblastoma cells. Invest. Ophthalmol. Vis. Sci. 29:1988;1517-1522.
11. Colston K.W., Hansen C.M. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr. Relat. Cancer. 9:2001;45-59.
12. Compton M.M. A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metastasis Rev. 11:1992;105-119.
13. Coupland S.E., Bechrakis N., Schuler A., Anagnostopoulos I., Hummel M., Bornfeld N., Stein H. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma. Br. J. Ophthalmol. 82:1998;961-970.
14. Dusso A.S., Brown A.J. Mechanism of vitamin D action and its regulation. Am. J. Kidney Dis. 32:1998;S13-S24.
15. 3 analogs and 9-cis retinoic acid. J. Clin. Invest. 99:1997;349-360.
16. Friend S.H., Bernards R., Rogelj S., Weinberg R.A., Rapaport J.M., Albert D.M., Dryja T.P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 323:1986;643-646.
17. Fung Y.K., Murphree A.L., T'Ang A., Qian J., Hinrichs S.H., Benedict W.F. Structural evidence for the authenticity of the human retinoblastoma gene. Science. 236:1987;1657-1661.
18. Gangwar D.N., Jain I.S., Gupta A., Sharma P.C. Bilateral spontaneous regression of retinoblastoma with dominant transmission. Ann. Ophthalmol. 14:1982;479-480.
19. Giuliano M., Vento R., Lauricella M., Calvaruso G., Carabillo M., Tesoriere G. Role of insulin-like growth factors in autocrine growth of human retinoblastoma Y79 cells. Eur. J. Biochem. 236:1996;523-532.
20. Gumireddy K., Reddy G.S., Ikegaki N., Binderup L., Sutton L.N., Phillips P.C., Damodar Reddy C. Anti-proliferative effects of 20-epi-vitamin-D(3) analogue, KH1060 in human neuroblastoma: induction of RAR-beta and p21(Cip1). Cancer Lett. 10:2003;51-60.
21. 3 in prostate cancer. Mol. Cancer Ther. 1:2002;667-677.
22. Kivela T. Parvalbumin, a horizontal cell-associated calcium-binding protein in retinoblastoma eyes. Invest. Ophthalmol. Vis. Sci. 39:1998;1044-1048.
23. Kyritsis A.P., Tsokos M., Chader G.J. Control of retinoblastoma cell growth by differentiating agents: current work and future directions. Anticancer Res. 6:1986;465-473.
24. Kyritsis A.P., Tsokos M., Triche T.J., Chader G.J. Retinoblastoma - origin from a primitive neuroectodermal tumor cell? Nature. 307:1984;471-473.
25. Lee W.H., Bookstein R., Hong F., Young L.J., Shew J.Y., Lee E.Y. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science. 235:1987;1394-1399.
26. Lee E.Y., Bookstein R., Young L.J., Lin C.J., Rosenfeld M.G., Lee W.H. Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma cell line Y79. Proc. Natl. Acad. Sci. USA. 85:1988;6017-6021.
27. Mahoney M.C., Burnett W.S., Majerovics A., Tanenbaum H. The epidemiology of ophthalmic malignancies in New York State. Ophthalmology. 97:1990;1143-1147.
28. Mathiasen I.S., Lademann U., Jaattela M. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. Cancer Res. 59:1999;4848-4856.
29. Mathiasen I.S., Sergeev I.N., Bastholm L., Elling F., Norman A.W., Jaattela M. Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells. J. Biol. Chem. 277:2002;30738-30745.
30. Narvaez C.J., Welch J. Role of mitochondria and caspases in vitamin D mediated apoptosis of MCF-7 breast cancer cells. J. Biol. Chem. 276:2001;9101-9107.
31. Nork T.M., Poulsen G.L., Millecchia L.L., Jantz R.G., Nickells R.W. p53 regulates apoptosis in human retinoblastoma. Arch. Ophthalmol. 115:1997;213-219.
32. Nork T.M., Schwartz T.L., Doshi H.M., Millecchia L.L. Retinoblastoma. Cell of origin. Arch. Ophthalmol. 113:1995;791-802.
33. Norton A.J., Jordan S., Yeomans P. Brief, high temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J. Pathol. 173:1994;371-379.
34. Pendergrass T.W., Davis S. Incidence of retinoblastoma in the United States. Arch. Ophthalmol. 98:1980;1204-1210.
35. Perentes E., Herbort C.P., Rubinstein L.J., Herman M.M., Uffer S., Donoso L.A., Collins V.P. Immunohistochemical characterization of human retinoblastomas in situ with multiple markers. Am. J. Ophthalmol. 103:1987;647-658.
36. Reid T.W., Albert D.M., Rabson A.S., Russell P., Craft J., Chu E.W., Tralka T.S., Wilcox J.L. Characteristics of an established cell line of retinoblastoma. J. Natl. Cancer Inst. 53:1974;347-352.
37. 3 in athymic mice with Y79 human retinoblastoma tumors. Arch. Ophthalmol. 117:1999;365-370.
38. Saulenas A.M., Cohen S.M., Key L.L., Winter C., Albert D.M. Vitamin D and retinoblastoma. The presence of receptors and inhibition of growth in vitro. Arch. Ophthalmol. 106:1988;533-535.
39. Shokravi M.T., Marcus D.M., Alroy J., Egan K., Saornil M.A., Albert D.M. Vitamin D inhibits angiogenesis in transgenic murine retinoblastoma. Invest. Ophthalmol. Vis. Sci. 36:1995;83-87.
40. 3 analogue in transgenic mice with retinoblastoma. Arch. Ophthalmol. 114:1996;1396-1401.
41. Tso M.O., Fine B.S., Zimmerman L.E. The nature of retinoblastoma. II. Photoreceptor differentiation: an electron microscopic study. Am. J. Ophthalmol. 69:1970;350-359.
42. Wagner N., Wagner K.D., Schley G., Coupland S.E., Heimann H., Grantyn R., Scholz H. The Wilms' tumor suppressor Wt1 is associated with the differentiation of retinoblastoma cells. Cell Growth Differ. 13:2002;297-305.
43. Wagner N., Wagner K.D., Sefton M., Rodriguez-Tébar A., Grantyn R. An abnormal response of retinoblastoma cells (Y-79) to neurotrophins. Invest. Ophthalmol. Vis. Sci. 41:2000;1932-1939.
44. Wagner K.D., Wagner N., Sukhatme V.P., Scholz H. Activation of vitamin D receptor by the Wilms' tumor gene product mediates apoptosis of renal cells. J. Am. Soc. Nephrol. 12:2001;1188-1196.
45. 3 in transgenic mice. Clin. Cancer Res. 4:1998;2253-2256.
46. Zhu X., Dunn J.M., Goddard A.D., Squire J.A., Becker A., Phillips R.A., Gallie B.L. Mechanisms of loss of heterozygosity in retinoblastoma. Cytogenet. Cell. Genet. 59:1992;248-252.